Osteopore (ASX:OSX) has announced that US-based distributor Bioplate has secured a non-exclusive agreement with MellingMedical to promote and sell its products within healthcare facilities owned or operated by the US government.
Osteopore secures US distribution agreement for government facilities
August 4, 2022 Australian Biotech
Latest Video
New Stories
-
First patient enrolled in new trial of NovoSorb SynPath treatment
August 11, 2022 - - Australian Biotech -
Partrys' candidate in combination improves survival in brain cancer model
August 11, 2022 - - Australian Biotech -
Scrapped COVIDSafe app only identified two positive cases
August 11, 2022 - - Other Health -
Compare the Market investor moves to acquire all of iSelect
August 11, 2022 - - Other Health -
New report promotes expansion of short-stay hospital program
August 11, 2022 - - Other Health -
Critical decisions over two months and four sitting weeks
August 11, 2022 - - Latest News -
UK push to lead the world on genetic profiling of cancer patients
August 11, 2022 - - Latest News